NZX 50 Rises Ahead of RBNZ Decision
2026-05-26 23:10
By
Joshua Ferrer
1 min. read
The NZX 50 rose 50 points, or 0.4% to 13,100 on Wednesday morning trade, extending gains from the previous session to hit a fresh two-week high, mainly supported by advances in healthcare, financial, and real estate stocks.
In the healthcare sector, heavyweight Fisher & Paykel Healthcare extended gains, up over 1% to a one-month high, after reporting higher annual net profit.
Infratil, an infrastructure investment company, also climbed 0.9% after posting a net surplus for the fiscal year, compared to a loss a year earlier.
Additionally, real estate developers traded in the green, including Kiwi Property (+0.5%), Argosy Property (+1.5%), and Stride Property Group (+0.9%).
Investors now await the monetary policy decision from the RBNZ later today, which is widely expected to keep rates unchanged, as well as the release of the government's 2026 budget.
Elsewhere, optimism for a US-Iran peace deal, despite military strikes in the Persian Gulf, continued to support global risk sentiment.